Strategic funding ChrysCapital is a well-established India-focused PE/VC group with over $8B raised across 10 funds and $5.5B deployed across 110+ deals, indicating strong capital reserves and a track record that can support scaling financing conversations and co-investment opportunities.

Sector expertise The firm targets Business Services, Financial Services, Pharma, Consumer, New Economy, Healthcare Services, and Manufacturing, suggesting potential cross-sell opportunities across portfolio companies and related investment theses in these high-growth sectors.

Strategic exits Historical exits of $8B and 2.7x ROI across 75+ exits demonstrate disciplined value creation and exit readiness, making ChrysCapital a potential partner for follow-on rounds, secondary sales, or advisory roles in mature portfolio companies.

Recent activity Active 2024–2026 with notable investments in La Renon Healthcare, Eris Lifesciences, MoEngage, and Healthkart, plus involvement in Novartis asset transactions, signaling ongoing appetite for growth-stage investments and strategic acquisitions.

Partnership potential As a registered SEBI RPM and AIF manager with a large LP base including sovereign funds and pension funds, ChrysCapital can be a credible co-investor, fund-of-funds partner, or advisory collaborator for capital stacking, fundraisers, and cross-border investment initiatives.